Showing results (71-80 of 160) with videos related to

Sort By:
Pageof 16
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 24, 2005
Health and economic consequences of sevelamer use for hyperphosphatemia in patients on hemodialysisKrista F Huybrechts, J Jaime Caro, David A Wilson, et al.
Infection Control and Hospital Epidemiology|October 11, 2007
The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequencesJudith A O'Brien, Betsy J Lahue, J Jaime Caro, et al.
Revista De Neurologia|June 23, 2010
[Cost-effectiveness analysis of using high doses of atorvastatin for the secondary stroke prevention in Spain]Arantzazu Arrospide, Javier Mar, José Vivancos-Mora, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2012
Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--4Jonathan Karnon, James Stahl, Alan Brennan, et al.
The Journal of Biological Chemistry|February 18, 2003
MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300Nianli Sang, Daniel P Stiehl, Jolene Bohensky, et al.
The American Journal of Managed Care|July 18, 2003
Allocating funds for cardiovascular disease prevention in light of the NCEP ATP III guidelinesJaime Caro, Krista F Huybrechts, Wendy S Klittich, et al.
Current Medical Research and Opinion|July 19, 2006
Modelling the economic and health consequences of cardiac resynchronization therapy in the UKJ Jaime Caro, Shien Guo, Alexandra Ward, et al.
Infection Control and Hospital Epidemiology|March 31, 2005
Health and economic consequences of an outbreak of pertussis among healthcare workers in a hospital in FranceAlexandra Ward, Jaime Caro, Laurence Bassinet, et al.
Pageof 16